neama labeb ismail emam
Asst. Lecturer
The Role of Nuclear Enriched Abundant Transcript 1 (NEAT1) as a Novel Marker in Diagnosis of Systemic Lupus Erythematosus Disease in Benha University Hospital
• 2026
Publication Information
Authors
Amany K. Shahat, 1Ahmed S. Osman, 1EL Sayed M. Abd EL Ghany, 1Neama L. Ismail*,
2Noha H. Ibrahim
Keywords
Not Available
Journal
Not Available
Publisher
Not Available
Volume
Not Available
Issue
Not Available
Pages
Not Available
publication.type
Local
Paper Link
Not Available
Supplementary Materials
Not Available
Abstract
Background: A persistent autoimmune condition with a variety of symptoms is systemic
lupus erythematosus. Reliable biomarkers that support diagnosis and reflect disease
activity remain clinically valuable Objectives: Our study pointed out to assess Nuclear
enriched abundant transcript 1 (NEAT1) expression as a diagnostic marker for SLE and
to explore association with activity and severity of the disease. Methodology: Twenty
age and sex-matched healthy controls and thirty SLE patients who met SLICC criteria
were included in this case-control study. NEAT1 expression was relatively quantified in
PBMCs utilizing quantitative real-time PCR. Standard laboratory indices (ESR, CRP,
complements, ANA) were assessed and anti-dsDNA was detected by using indirect
immunofluorescent test (IIFT) also SLEDAI score was used to measure disease activity.
Results: Females predominated among SLE cases (83.3% vs 70.0% in controls;
P=0.311) with no significant age difference (33.60±11.04 vs 31.15±10.26 years;
P=0.367). Expression level of NEAT1 was higher in cases than controls (9.62±29.02 vs
8.41±19.55; P=0.010). NEAT1 positively correlated with 24-hour proteinuria ( P
lupus erythematosus. Reliable biomarkers that support diagnosis and reflect disease
activity remain clinically valuable Objectives: Our study pointed out to assess Nuclear
enriched abundant transcript 1 (NEAT1) expression as a diagnostic marker for SLE and
to explore association with activity and severity of the disease. Methodology: Twenty
age and sex-matched healthy controls and thirty SLE patients who met SLICC criteria
were included in this case-control study. NEAT1 expression was relatively quantified in
PBMCs utilizing quantitative real-time PCR. Standard laboratory indices (ESR, CRP,
complements, ANA) were assessed and anti-dsDNA was detected by using indirect
immunofluorescent test (IIFT) also SLEDAI score was used to measure disease activity.
Results: Females predominated among SLE cases (83.3% vs 70.0% in controls;
P=0.311) with no significant age difference (33.60±11.04 vs 31.15±10.26 years;
P=0.367). Expression level of NEAT1 was higher in cases than controls (9.62±29.02 vs
8.41±19.55; P=0.010). NEAT1 positively correlated with 24-hour proteinuria ( P